0001700326-17-000001.txt : 20170731 0001700326-17-000001.hdr.sgml : 20170731 20170728182952 ACCESSION NUMBER: 0001700326-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170731 DATE AS OF CHANGE: 20170728 EFFECTIVENESS DATE: 20170731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Abogen, Inc. CENTRAL INDEX KEY: 0001700326 IRS NUMBER: 275325787 STATE OF INCORPORATION: ME FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291763 FILM NUMBER: 17991176 BUSINESS ADDRESS: STREET 1: 477 CONGRESS STREET, SUITE 1010 CITY: PORTLAND STATE: ME ZIP: 04101 BUSINESS PHONE: (207) 939-1665 MAIL ADDRESS: STREET 1: 477 CONGRESS STREET, SUITE 1010 CITY: PORTLAND STATE: ME ZIP: 04101 D 1 primary_doc.xml X0708 D LIVE 0001700326 Abogen, Inc. 477 CONGRESS STREET, SUITE 1010 PORTLAND ME MAINE 04101 (207) 939-1665 MAINE None None Corporation true Stephen Andrews 477 Congress Street Suite 1010 Portland ME MAINE 04101 Executive Officer Director Promoter Mr. Andrews serves as the Chief Executive Officer and is a Director and a Promoter of AboGen, Inc. Youssef Biahillah 477 Congress Street Suite 1010 Portland ME MAINE 04101 Executive Officer Director Promoter Mr. Biadillah serves as the Chief Operating Officer and is a Director and Promoter of AboGen, Inc. Michael Steele 477 Congress Street Suite 1010 Portland ME MAINE 04101 Executive Officer Mr. Steele serves as the Chief Business Officer of AboGen, Inc. Manasi Pancholy Jain 477 Congress Street Suite 1010 Portland ME MAINE 04101 Executive Officer Ms. Jain serves as a Vice President of AboGen, Inc. Jacques Essinger 477 Congress Street Suite 1010 Portland ME MAINE 04101 Director Mr. Essinger serves as a Director of AboGen, Inc. Ken Martin 477 Congress Street Suite 1010 Portland ME MAINE 04101 Director Mr. Martin serves as a Director of AboGen, Inc. Fred Heimann 477 Congress Street Portland ME MAINE 04101 Director Mr. Heimann serves as a Director of AboGen, Inc. Biotechnology Decline to Disclose 06b false 2017-07-28 false true false 10000 PHX Financial, Inc. d/b/a Phoenix Financial Services 144403 None None 100 Wall Street 10th Floor New York NY NEW YORK 10005 All States false 4000000 25000 3975000 false 1 520000 true 0 PHX Financial is to receive 10% of aggregate gross proceed as commission, and 3% as non-accountable cash expenses. PHX is separately compensated for general investment banker services, not variable with amount of securities sold. 1200000 true Company projects salaries of $1,200,000 to four executives over next two years; actual amounts will vary false Abogen, Inc. Stephen D. Andrews Stephen D. Andrews Chief Executive Officer and Director 2017-07-28